Augmedics
Stage
DivestitureTotal Raised
$143.28MInvestors Count
14Deal Terms
1Portfolio Exits
1Funding, Valuation & Revenue
8 Fundings
Augmedics has raised $143.28M over 8 rounds.
Augmedics's latest funding round was a Series D for $82.5M on June 27, 2023.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
6/27/2023 | Series D | $82.5M | CPMG, Almeda Ventures, Evidity Health Capital, H.I.G. Capital, Revival Healthcare Capital, and Undisclosed Investors | 4 | ||
3/30/2021 | Series C | |||||
6/15/2020 | Series B | |||||
4/16/2020 | Loan | |||||
9/18/2017 | Series A |
Date | 6/27/2023 | 3/30/2021 | 6/15/2020 | 4/16/2020 | 9/18/2017 |
|---|---|---|---|---|---|
Round | Series D | Series C | Series B | Loan | Series A |
Amount | $82.5M | ||||
Investors | CPMG, Almeda Ventures, Evidity Health Capital, H.I.G. Capital, Revival Healthcare Capital, and Undisclosed Investors | ||||
Valuation | |||||
Revenue | |||||
Sources | 4 |
Augmedics Deal Terms
1 Deal Term
Augmedics's deal structure is available for 1 funding round, including their Series A from September 18, 2017.
Round | Series A |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A |
Augmedics Investors
14 Investors
Augmedics has 14 investors. Almeda Ventures invested in Augmedics's Series D funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
3/30/2021 | 6/27/2023 | 2 Series C, Series D (2023) | Venture Capital | Israel | ||
3/30/2021 | 6/27/2023 | 2 Series C, Series D (2023) | Private Equity | Texas | ||
3/30/2021 | 6/27/2023 | 2 Series C, Series D (2023) | Asset/Investment Management | Florida | ||
Venture Capital | New York | |||||
Private Equity | Texas |
First funding | 3/30/2021 | 3/30/2021 | 3/30/2021 | ||
|---|---|---|---|---|---|
Last Funding | 6/27/2023 | 6/27/2023 | 6/27/2023 | ||
Investor | |||||
Rounds | 2 Series C, Series D (2023) | 2 Series C, Series D (2023) | 2 Series C, Series D (2023) | ||
Board Seats | |||||
Type | Venture Capital | Private Equity | Asset/Investment Management | Venture Capital | Private Equity |
Location | Israel | Texas | Florida | New York | Texas |
Augmedics Acquisitions
1 Acquisition
Augmedics acquired 1 company. Their latest acquisition was Surgalign - Digital Health Business on July 31, 2023.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
7/31/2023 | Acquired Unit | 1 |
Date | 7/31/2023 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Acquired Unit |
Sources | 1 |
Augmedics Portfolio Exits
1 Portfolio Exit
Augmedics has 1 portfolio exit. Their latest portfolio exit was Augmedics - xvision Spine System Business on February 17, 2026.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
2/17/2026 | Divestiture | Augmedics - xvision Spine System Business | VB Spine | 2 |
Date | 2/17/2026 |
|---|---|
Exit | Divestiture |
Companies | Augmedics - xvision Spine System Business |
Valuation | |
Acquirer | VB Spine |
Sources | 2 |
Compare Augmedics to Competitors
Osso VR provides healthcare training and assessment solutions within the medical device and healthcare sectors. The company has a virtual reality platform for surgical training and professional development, offering learning experiences. It was founded in 2016 and is based in San Francisco, California.
Avatar Medical develops three-dimensional (3D) medical imaging and extended reality (XR) visualization technology for the healthcare sector. The company provides software solutions that convert medical images into interactive 3D avatars, which assist in patient consultations, surgical planning, and medical education. Avatar Medical serves the healthcare industry with applications in neurosurgery, oncology, and cardiovascular surgery. It was founded in 2020 and is based in Paris, France.
AIBODY develops digital physiology software for the healthcare sector. Its software simulates physiological processes using digital physiology models that represent various human body functions and pharmacokinetics. AIBODY's products support medical education and training and offer solutions for managing cardiovascular disease. It was founded in 2020 and is based in London, United Kingdom.
ORamaVR provides medical extended reality (XR) training within the healthcare sector. It offers an IT platform called MAGES-SDK that supports the creation of medical XR simulations for training and assessment. Its simulations are used by hospitals, medical device companies, medical schools, and training centers. ORamaVR was formerly known as Ovid VR. It was founded in 2016 and is based in Geneva, Switzerland.
MediView develops augmented reality-powered medical imaging solutions for the healthcare sector. The company provides visualization and navigation systems for surgical procedures, offering real-time 3D holographic views of patient anatomy to assist clinicians during interventions. MediView's technology supports remote collaboration and telehealth services, allowing for communication and guidance among medical professionals. It was founded in 2017 and is based in Cleveland, Ohio.
Surgical Theater develops experiential reality (XR) technology within the healthcare sector and focuses on surgical applications and patient engagement. The company provides XR products that assist in surgical planning, offer visualization during operations, and facilitate patient understanding of their medical procedures. Its solutions are utilized by medical institutions in relation to surgical practices and patient outcomes. It was founded in 2010 and is based in Beachwood, Ohio.
Loading...